182 related articles for article (PubMed ID: 28688278)
1. Design, synthesis, and biological evaluation of optimized phthalazine derivatives as hedgehog signaling pathway inhibitors.
Lu X; Peng Y; Wang C; Yang J; Bao X; Dong Q; Zhao W; Tan W; Dong X
Eur J Med Chem; 2017 Sep; 138():384-395. PubMed ID: 28688278
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of novel dimethylpyridazine derivatives as hedgehog signaling pathway inhibitors.
Wang C; Zhu M; Lu X; Wang H; Zhao W; Zhang X; Dong X
Bioorg Med Chem; 2018 Jul; 26(12):3308-3320. PubMed ID: 29739714
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of novel benzylphthalazine derivatives as hedgehog signaling pathway inhibitors.
Bao X; Peng Y; Lu X; Yang J; Zhao W; Tan W; Dong X
Bioorg Med Chem Lett; 2016 Jul; 26(13):3048-3051. PubMed ID: 27180012
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
5. Novel 4-(2-pyrimidinylamino)benzamide derivatives as potent hedgehog signaling pathway inhibitors.
Xin M; Zhang L; Tu C; Tang F; Wen J
Bioorg Med Chem; 2018 Oct; 26(18):5029-5036. PubMed ID: 30249494
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, and Structure-Activity Relationship of Tetrahydropyrido[4,3-d]pyrimidine Derivatives as Potent Smoothened Antagonists with in Vivo Activity.
Lu W; Liu Y; Ma H; Zheng J; Tian S; Sun Z; Luo L; Li J; Zhang H; Yang ZJ; Zhang X
ACS Chem Neurosci; 2017 Sep; 8(9):1980-1994. PubMed ID: 28618224
[TBL] [Abstract][Full Text] [Related]
7. Discovery of pyrrolo[3,2-c]quinoline-4-one derivatives as novel hedgehog signaling inhibitors.
Ohashi T; Oguro Y; Tanaka T; Shiokawa Z; Shibata S; Sato Y; Yamakawa H; Hattori H; Yamamoto Y; Kondo S; Miyamoto M; Tojo H; Baba A; Sasaki S
Bioorg Med Chem; 2012 Sep; 20(18):5496-506. PubMed ID: 22910224
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of structurally modified isoindolinone and quinazolinone derivatives as hedgehog pathway inhibitors.
Bhattarai D; Jung JH; Han S; Lee H; Oh SJ; Ko HW; Lee K
Eur J Med Chem; 2017 Jan; 125():1036-1050. PubMed ID: 27810591
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic-pharmacodynamic analysis of vismodegib in preclinical models of mutational and ligand-dependent Hedgehog pathway activation.
Wong H; Alicke B; West KA; Pacheco P; La H; Januario T; Yauch RL; de Sauvage FJ; Gould SE
Clin Cancer Res; 2011 Jul; 17(14):4682-92. PubMed ID: 21610148
[TBL] [Abstract][Full Text] [Related]
10. Design of 1-piperazinyl-4-arylphthalazines as potent Smoothened antagonists.
Lucas BS; Aaron W; An S; Austin RJ; Brown M; Chan H; Chong A; Hungate R; Huang T; Jiang B; Johnson MG; Kaizerman JA; Lee G; McMinn DL; Orf J; Powers JP; Rong M; Toteva MM; Uyeda C; Wickramasinghe D; Xu G; Ye Q; Zhong W
Bioorg Med Chem Lett; 2010 Jun; 20(12):3618-22. PubMed ID: 20493695
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D3 analogues that contain modified A- and seco-B-rings as hedgehog pathway inhibitors.
DeBerardinis AM; Raccuia DS; Thompson EN; Maschinot CA; Kyle Hadden M
Eur J Med Chem; 2015 Mar; 93():156-71. PubMed ID: 25676864
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of anthranilamide derivatives as potent SMO inhibitors.
Ji D; Zhang W; Xu Y; Zhang JJ
Bioorg Med Chem; 2020 Mar; 28(6):115354. PubMed ID: 32063403
[TBL] [Abstract][Full Text] [Related]
13. Introduction of fluorine to phenyl group of 4-(2-pyrimidinylamino)benzamides leading to a series of potent hedgehog signaling pathway inhibitors.
Xin M; Zhang L; Wen J; Shen H; Zhao X; Jin Q; Tang F
Bioorg Med Chem Lett; 2017 Aug; 27(15):3259-3263. PubMed ID: 28642101
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anticancer activities of novel 1,2,4-triazolo[3,4-a]phthalazine derivatives.
Xue DQ; Zhang XY; Wang CJ; Ma LY; Zhu N; He P; Shao KP; Chen PJ; Gu YF; Zhang XS; Wang CF; Ji CH; Zhang QR; Liu HM
Eur J Med Chem; 2014 Oct; 85():235-44. PubMed ID: 25086915
[TBL] [Abstract][Full Text] [Related]
15. Discovery of the investigational drug TAK-441, a pyrrolo[3,2-c]pyridine derivative, as a highly potent and orally active hedgehog signaling inhibitor: modification of the core skeleton for improved solubility.
Ohashi T; Oguro Y; Tanaka T; Shiokawa Z; Tanaka Y; Shibata S; Sato Y; Yamakawa H; Hattori H; Yamamoto Y; Kondo S; Miyamoto M; Nishihara M; Ishimura Y; Tojo H; Baba A; Sasaki S
Bioorg Med Chem; 2012 Sep; 20(18):5507-17. PubMed ID: 22898254
[TBL] [Abstract][Full Text] [Related]
16. Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and
Khalifa MM; Al-Karmalawy AA; Elkaeed EB; Nafie MS; Tantawy MA; Eissa IH; Mahdy HA
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):299-314. PubMed ID: 34894955
[TBL] [Abstract][Full Text] [Related]
17. Discovery, mechanism and metabolism studies of 2,3-difluorophenyl-linker-containing PARP1 inhibitors with enhanced in vivo efficacy for cancer therapy.
Chen W; Guo N; Qi M; Dai H; Hong M; Guan L; Huan X; Song S; He J; Wang Y; Xi Y; Yang X; Shen Y; Su Y; Sun Y; Gao Y; Chen Y; Ding J; Tang Y; Ren G; Miao Z; Li J
Eur J Med Chem; 2017 Sep; 138():514-531. PubMed ID: 28692916
[TBL] [Abstract][Full Text] [Related]
18. Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: Design, synthesis and biological evaluation of 1-substituted-4-(4-methoxybenzyl)phthalazine derivatives.
Eldehna WM; Abou-Seri SM; El Kerdawy AM; Ayyad RR; Hamdy AM; Ghabbour HA; Ali MM; Abou El Ella DA
Eur J Med Chem; 2016 May; 113():50-62. PubMed ID: 26922228
[TBL] [Abstract][Full Text] [Related]
19. Five-membered heteroaromatic ring fused-pyrimidine derivatives: design, synthesis, and hedgehog signaling pathway inhibition study.
Zhang L; Xin M; Shen H; Wen J; Tang F; Tu C; Zhao X; Wei P
Bioorg Med Chem Lett; 2014 Aug; 24(15):3486-92. PubMed ID: 24923765
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and evaluation of hybrid vitamin D3 side chain analogues as hedgehog pathway inhibitors.
Banerjee U; DeBerardinis AM; Hadden MK
Bioorg Med Chem; 2015 Feb; 23(3):548-55. PubMed ID: 25549899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
